160 related articles for article (PubMed ID: 34208476)
1. Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis.
Hibbert J; Halec G; Baaken D; Waterboer T; Brenner N
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208476
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
Kusters JMA; Diergaarde B; Ness A; Schim van der Loeff MF; Heijne JCM; Schroeder L; Hueniken K; McKay JD; Macfarlane GJ; Lagiou P; Lagiou A; Polesel J; Agudo A; Alemany L; Ahrens W; Healy CM; Conway DI; Robinson M; Canova C; Holcátová I; Richiardi L; Znaor A; Pring M; Thomas S; Hayes DN; Liu G; Hung RJ; Brennan P; Olshan AF; Virani S; Waterboer T
Int J Cancer; 2024 Jan; 154(2):389-402. PubMed ID: 37694289
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
5. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study.
Busch CJ; Hoffmann AS; Viarisio D; Becker BT; Rieckmann T; Betz C; Bender N; Schroeder L; Hussein Y; Petersen E; Jagodzinski A; Schäfer I; Burandt E; Lang Kuhs K; Pawlita M; Waterboer T; Brenner N
EClinicalMedicine; 2022 Nov; 53():101659. PubMed ID: 36147627
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
Cancer Epidemiol; 2016 Jun; 42():46-52. PubMed ID: 27010729
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
9. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
[TBL] [Abstract][Full Text] [Related]
12. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
[TBL] [Abstract][Full Text] [Related]
13. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
14. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test.
Mirghani H; Casiraghi O; Guerlain J; Amen F; He MX; Ma XJ; Luo Y; Mourareau C; Drusch F; Lakdhar AB; Melkane A; St Guily L; Badoual C; Scoazec JY; Borget I; Aupérin A; Dalstein V; Vielh P
Oral Oncol; 2016 Nov; 62():101-108. PubMed ID: 27865361
[TBL] [Abstract][Full Text] [Related]
16. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.
Lang Kuhs KA; Wood CB; Wiggleton J; Aulino JM; Latimer B; Smith DK; Bender N; Rohde S; Mannion K; Kim Y; Sinard R; Langerman A; Fleischer A; Fakhry C; Waterboer T; Netterville JL
Cancer; 2020 Jun; 126(11):2658-2665. PubMed ID: 32129894
[TBL] [Abstract][Full Text] [Related]
17. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.
Randén-Brady R; Carpén T; Jouhi L; Syrjänen S; Haglund C; Tarkkanen J; Remes S; Mäkitie A; Mattila PS; Silén S; Hagström J
Hum Pathol; 2019 Aug; 90():97-105. PubMed ID: 31121191
[TBL] [Abstract][Full Text] [Related]
18. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
19. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
20. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
